Glioblastoma Clinical Trials in Phoenix, Arizona
7 recruitingPhoenix, Arizona
Showing 1–7 of 7 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Early Phase 1
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
Brain MetastasasesGlioblastoma (GBM)
Nader Sanai15 enrolled1 locationNCT07268053
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain TumorBrain Tumor - MetastaticBrain Tumor, Recurrent+3 more
GT Medical Technologies, Inc.600 enrolled54 locationsNCT04427384
Recruiting
Phase 3
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Brain TumorGlioblastomaGBM+1 more
Ivy Brain Tumor Center450 enrolled93 locationsNCT06388733
Recruiting
Early Phase 1
A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
GlioblastomaHigh Grade Glioma
St. Joseph's Hospital and Medical Center, Phoenix82 enrolled2 locationsNCT06072586
Recruiting
Early Phase 1
Clinical Trial of BMS-986504 in Recurrent GBM Patients
Glioblastoma WHO Grade IV
Nader Sanai9 enrolled1 locationNCT06883747
Recruiting
Early Phase 1
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
GlioblastomaGliomaGlioma, Malignant+1 more
Nader Sanai12 enrolled1 locationNCT05773326